# Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions

> **NCT04833465** · — · RECRUITING · sponsor: **Children's National Research Institute** · enrollment: 90 (estimated)

## Conditions studied

- Juvenile Idiopathic Arthritis
- Systemic Lupus Erythematosus
- Fibromyalgia

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT04833465
- **Lead sponsor:** Children's National Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-16
- **Primary completion:** 2026-04
- **Final completion:** 2027-04
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04833465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04833465, "Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04833465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*